1. To discuss the newly-validated ACR/EULAR Classification Criteria for IgG4-RD

2. To understand the implications of these criteria for clinical practice

3. To review what is known about the pathophysiology of IgG4-RD and how this knowledge impacts treatment decsions now

Session date: 
12/11/2018 - 8:30am to 9:30am CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
John Stone